UBS’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.56M Buy
43,144
+14,049
+48% +$784K ﹤0.01% 2675
2014
Q2
$1.37M Sell
29,095
-7,901
-21% -$357K ﹤0.01% 3255
2014
Q1
$1.58M Sell
36,996
-16,875
-31% -$745K ﹤0.01% 3014
2013
Q4
$2.27M Sell
53,871
-141,286
-72% -$6.15M ﹤0.01% 2690
2013
Q3
$8.04M Buy
195,157
+134,385
+221% +$5.62M 0.01% 1297
2013
Q2
$2.8M Buy
+60,772
New +$2.72M ﹤0.01% 2180

Other funds holding THC

UBS's THC Position: Q3 2014 in Review

UBS increased its Tenet Healthcare (THC) stake by 48% in Q3 2014, buying an estimated $784K and bringing the position to 43,144 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2675.

UBS first reported a position in THC in Q2 2013 and has held it in 6 quarters since. The position peaked at $8.04M in Q3 2013. 312 funds tracked by Wall St. Rank hold THC as of Q3 2014.

  • UBS held 43,144 shares of Tenet Healthcare worth $2.56M as of Q3 2014.
  • UBS bought 14,049 Tenet Healthcare shares in Q3 2014, an estimated $784K.
  • Tenet Healthcare made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2675 holding.
  • UBS first reported a position in Tenet Healthcare in Q2 2013 and has held it in 6 quarters since.
  • UBS's Tenet Healthcare position peaked at $8.04M in Q3 2013.
  • 312 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.